Skip to content
Film Television Auditions – Lifestyle
Author:
Chiesi Group
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
June 25, 2026